ConductScience.org, home

Paper42092016

Opportunities for antenatal medical treatment of genetic conditions: the earlier, the better.

Bianchi DW. Pediatr Res, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Opportunities for antenatal medical treatment of genetic conditions: the earlier, the better. Papers, record 42092016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42092016

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Opportunities for antenatal medical treatment of genetic conditions: the earlier, the better.
PubMed
Journal
Pediatr Res
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-10-23
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bianchi DWDiana W

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in42918831Correction: Opportunities for antenatal medical treatment of genetic conditions: the earlier, the better.https://conductscience.org/library/papers/42918831

Source PubMed

Download CSV of comments and corrections

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130067923Sequencing of Circulating Cell-free DNA during Pregnancy.N Engl J Med2018https://conductscience.org/library/papers/30067923PubMed
231264685Quantitative MRI Analyses of Regional Brain Growth in Living Fetuses with Down Syndrome.Cereb Cortex2020https://conductscience.org/library/papers/31264685PubMed
337544351Embryonic statistical analyses reveal 2 growth phenotypes in mouse models of Down syndrome.Am J Obstet Gynecol2024https://conductscience.org/library/papers/37544351PubMed
427586445An Integrated Human/Murine Transcriptome and Pathway Approach To Identify Prenatal Treatments For Down Syndrome.Sci Rep2016https://conductscience.org/library/papers/27586445PubMed
539533854Analysis of genotype effects and inter-individual variability in iPSC-derived trisomy 21 neural progenitor cells.Hum Mol Genet2025https://conductscience.org/library/papers/39533854PubMed
629199020The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations.Cell Syst2018https://conductscience.org/library/papers/29199020PubMed
733098770Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model.Am J Hum Genet2020https://conductscience.org/library/papers/33098770PubMed
839737640JAK inhibition decreases the autoimmune burden in Down syndrome.Elife2024https://conductscience.org/library/papers/39737640PubMed
936813963Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c+ B cells.Nature2023https://conductscience.org/library/papers/36813963PubMed
1039794210Absolute quantification of cell-free DNA for prenatal genetics and oncology.Trends Biotechnol2025https://conductscience.org/library/papers/39794210PubMed
1134268058A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy.Cureus2021https://conductscience.org/library/papers/34268058PubMed
1240754574PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report.J Cyst Fibros2025https://conductscience.org/library/papers/40754574PubMed
1339645477Outcomes of prenatal use of elexacaftor/tezacaftor/ivacaftor in carrier mothers to treat meconium ileus in fetuses with cystic fibrosis.J Cyst Fibros2025https://conductscience.org/library/papers/39645477PubMed
1435710144Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design.BMJ Open Respir Res2022https://conductscience.org/library/papers/35710144PubMed

Download CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CFTR1080PubTator's text mininghttps://conductscience.org/library/genes/1080

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42092016

GET https://conductscience.org/api/papers/v1/42092016/authors